GSK strikes deal for Quell wearable technology

19 January 2018 - Deborah Wilkes

Archived

GlaxoSmithKline Consumer Healthcare has struck a deal worth up to USD26.5 million for the Quell wearable pain relief technology from US-based NeuroMetrix.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: